WHO’s 2026 Eradication Budget Faces 70% Gap

Since 1988, we’ve seen a 99.9% drop in wild poliovirus cases, a direct result of international cooperation on disease eradication. The World Health Organization (WHO) is the one coordinating these campaigns, and they’re changing what’s possible in public health. The real question is, how well is the WHO actually handling the immense difficulties of wiping out a disease for good?

The Polio Paradox: Near Eradication, Persistent Threat

That 99.9% drop in wild polio since 1988 is a massive win for global health, thanks to the Global Polio Eradication Initiative (GPEI), the partnership of WHO, UNICEF, Rotary International, and the CDC, which has prevented millions of cases of paralysis. We’re down to just two countries, Afghanistan and Pakistan, from 125 back in 1988, because of relentless vaccination, sharp surveillance, and quick response. The GPEI says the final hurdle is reaching the last few kids in these holdouts and stamping out circulating vaccine-derived poliovirus (cVDPV) outbreaks. These cVDPV flare-ups happen when not enough people get vaccinated, giving the weakened live virus in the oral vaccine a chance to circulate and mutate back to a harmful form in under-immunized areas. In my view, the cVDPV problem is serious, but it doesn’t erase the incredible progress against wild polio. It just shows how brutally hard the last mile of eradication is in places with limited healthcare access and low trust. Plus, the polio infrastructure, all those surveillance networks and cold chains, is now a backbone for other public health work, a huge bonus people often forget.

Malaria’s Stubborn Grip: Setbacks in Key Regions

The fight against malaria is a lot messier than the official targets suggest. The WHO’s goal to eliminate it in 25 countries by 2025 is hitting major turbulence. In fact, 15 of those countries saw cases go *up* last year. That’s a bad sign. The World Malaria Report 2023 breaks down why: drug and insecticide resistance, not enough money, and wrecked health services from recent crises are all to blame. The WHO African Region is still getting hammered, with about 95% of all malaria cases and 96% of deaths. New tools like the RTS,S/AS01 malaria vaccine are promising, but only if we can get them to people who need them. From what I’ve seen, people think tech will solve it all, but that’s a huge oversimplification because climate change is giving mosquitoes new places to live and poverty means people can’t get nets or see a doctor in time. This is a socio-environmental problem as much as it is a medical one, and just handing out drugs isn’t going to cut it.

Measles and Rubella: The Power of Vaccination, the Peril of Hesitancy

With the Measles and Rubella Strategic Plan 2021-2025, we’ve managed to vaccinate over 1.2 billion kids and prevent an estimated 60 million deaths, a huge win for immunization in global health. But we’re not done. Measles outbreaks are still popping up, almost always in communities with low vaccination rates. According to the WHO’s latest data on measles, we need 95% two-dose coverage for herd immunity, but vaccine hesitancy and flat-out misinformation have pushed some places below that line. People talk about eradication, but do they grasp the insane logistics of getting a vaccine to every single child, particularly in war zones or remote villages? You need more than just vials. You need a working cold chain, trained people to give the shots, and a way to build trust in communities that have good reason to be skeptical. These outbreaks just prove where our public health outreach and systems are failing.

Neglected Tropical Diseases: Quiet Progress, Enduring Disparities

One of the biggest under-the-radar wins in disease eradication has been against Neglected Tropical Diseases (NTDs). From 2010 to 2023, we cut the number of people needing NTD interventions by a staggering 90%. We’re talking about 20 different diseases like lymphatic filariasis, trachoma, and river blindness that hit the world’s poorest people the hardest. The WHO’s roadmap, mass drug administration, vector control, better sanitation, has been key. We’re seeing real results, like Togo eliminating four NTDs by 2020, a first in sub-Saharan Africa according to the WHO. This program, built on donated drugs and pharma partnerships, proves what can be done with global alignment. Everyone talks about HIV, TB, and Malaria, but the NTD story proves that steady, focused work gets results, even without the media spotlight. I think the reason it worked is because the interventions for many NTDs are cheap and simple, and we had long-term buy-in from donors and the countries themselves. It’s a model that could work for other diseases if the political will and funding are there.

The Funding Gap: A Shadow Over Future Eradication Efforts

For all this progress, a huge problem is threatening the WHO’s future disease eradication work: money. Specifically, the lack of it. Voluntary contributions only cover 30% of the WHO’s 2026 disease eradication budget. This kind of shortfall, which you can see in the WHO’s own financial reports, puts planned campaigns on ice and cripples the ability to react to new threats. Relying on voluntary money, which is usually tied to specific pet projects, is no way to run a global health program. It means core work like surveillance and research is always on the chopping block, especially for diseases that are almost gone but need that final push. This is about predictability and flexibility. You can’t do long-term planning or mount a fast emergency response when you don’t know where next year’s budget is coming from. Money pours in during a crisis, but it’s the steady, boring investment in immunization and surveillance that stops those crises in the first place. The biggest threat we face isn’t a lack of science. It’s a lack of consistent political and financial will. Thinking we can just stop funding a program when a disease is 99% gone is a recipe for disaster. The WHO has driven huge successes but also faced big setbacks, and the difference often comes down to this. If we want a world without these diseases, we need steady funding and real political backbone. After all, disease is an economic indicator, and fixing it takes a real strategy. You can see more on how these things are structured in the plans for the WHO’s 2026 Digital Health Plan.